Stay updated on ILIxadencel + CPI in Tumors Clinical Trial
Sign up to get notified when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.

Latest updates to the ILIxadencel + CPI in Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check23 days agoChange DetectedThe name 'PPD Development, LP' has been updated to a different case format, changing from all uppercase to title case.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check58 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of the Phase 1b and Phase 2 study protocols for the immunotherapy ilixadencel, while adding new information about the study's collaborators and a revision update.SummaryDifference25%
- Check66 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to ILIxadencel + CPI in Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.